-
公开(公告)号:EP4512815A2
公开(公告)日:2025-02-26
申请号:EP24209420.9
申请日:2020-09-03
Applicant: GE Healthcare AS
Inventor: BALES, Brian, C. , RISHEL, Michael James , DINN, Sean
IPC: C07F13/00
Abstract: The invention relates to isomers of chelate compounds and their use as contrast agents in magnetic resonance imaging (MRI) procedures.
-
公开(公告)号:EP4466276A1
公开(公告)日:2024-11-27
申请号:EP23703510.0
申请日:2023-01-13
Applicant: Elkem Silicones France SAS , Centre National de la Recherche Scientifique , UNIVERSITE CLAUDE BERNARD - LYON 1 , CPE Lyon
Inventor: MIRGALET, Raphaël , VIVIEN, Anthony , CAMP, Clément , VEYRE, Laurent , THIEULEUX, Chloé
-
公开(公告)号:EP4377308B1
公开(公告)日:2024-11-20
申请号:EP22782448.9
申请日:2022-09-09
Inventor: POLASEK, Miloslav , DAVID, Tomas , STRAKA, Michal , JAROS, Adam
-
4.
公开(公告)号:EP3160514B1
公开(公告)日:2024-07-31
申请号:EP15812491.7
申请日:2015-06-22
IPC: A61K51/04 , A61K103/00 , C07B59/00 , C07F13/00
CPC classification number: A61K51/0478 , A61K51/0487 , A61K51/0497 , C07F13/00 , C07F13/005 , A61K51/0402 , C07B59/004
-
-
公开(公告)号:EP3334464B1
公开(公告)日:2024-04-10
申请号:EP16835998.2
申请日:2016-08-12
Inventor: GALE, Eric M. , CARAVAN, Peter
IPC: A61K49/06 , C07F13/00 , C07D213/80 , C07D213/87 , C07D217/14 , C07D233/58 , C07D235/14 , C07D213/40 , C07D213/65 , C07D213/68 , C07K7/06 , C07K7/08 , A61K49/08 , A61K49/14 , A61K49/10
-
公开(公告)号:EP4093742A1
公开(公告)日:2022-11-30
申请号:EP21733066.1
申请日:2021-06-02
Inventor: BICE, Ismet , GREIMANN, Heiko
-
公开(公告)号:EP4025259A1
公开(公告)日:2022-07-13
申请号:EP20767545.5
申请日:2020-09-03
Applicant: GE Healthcare AS
Inventor: BALES, Brian, C , RISHEL, Michael, James , DINN, Sean, R
IPC: A61K49/10 , C07D471/08 , C07F13/00
-
公开(公告)号:EP3738967A1
公开(公告)日:2020-11-18
申请号:EP20168046.9
申请日:2016-08-11
Applicant: Galera Labs, LLC
Inventor: KEENE, Jeffery L. , SCHALL, Otto F. , RILEY, Dennis P.
IPC: C07F13/00 , C07F15/02 , C07F15/04 , C07F1/08 , A61K9/00 , A61K47/14 , A61P1/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00
Abstract: Aspects of the present disclosure relate to compounds which have enhanced oral bioavailability. A transition metal complex includes a transition metal coordinated by a macrocycle comprising the pentaaza 15-membered macrocyclic ring corresponding to Formula A and two axial ligands having the formula -OC(O)X1. (Formula A) each of the two axial ligands has the formula -OC(=O)X1 wherein each X1 is independently substituted or unsubstituted phenyl or -C(-X2)(-X3)(-X4); each X2 is independently substituted or unsubstituted phenyl, or substituted or unsubstituted alkyl; each X3 is independently hydrogen, hydroxyl, alkyl, amino, -X5C(=O)R13 where X5 is NH or O, and R13 is C1-C18 alkyl, substituted or unsubstituted aryl or C1-C18 aralkyl, or -OR14, where R14 is C1-C18 alkyl, substituted or unsubstituted aryl or C1-C18 aralkyl, or together with X4 is (=O); and each X4 is independently hydrogen or together with X3 is (=O).
-
公开(公告)号:EP3649140A1
公开(公告)日:2020-05-13
申请号:EP18733554.2
申请日:2018-06-18
Applicant: Ruhr-Universität Bochum
Inventor: METZLER-NOLTE, Nils , SIEGMUND, Daniel , BANDOW, Julia , SCHÄKERMANN, Sina
IPC: C07F13/00 , A61K31/4184 , A61K31/4188 , A61P31/04
-
-
-
-
-
-
-
-
-